Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Today: 27/07/2026 · PREPARE NOW · Open · Viewed
Funding agency: Horizon Europe
Call: HORIZON-MISS-2026-02
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions | Deadline model: single-stage | Planned opening: 10/02/2026 | Model Grant Agreement: HORIZON Lump Sum Grant
The aim is to implement a robust and pragmatic approach to optimize immunotherapeutic interventions for patients with refractory cancers. The call aims to support innovative ideas that can lead to clinical trials.
Budget total: — EUR | Budget per project: — EUR
Deadline: 15/09/2026 (50 days left) | Duration: — months | Funding intensity: —% | Type: research
Eligibility: entity types: research, institution; countries: EU member states, associated countries
#cancer#immunotherapy#clinical trials#Horizon Europe
HealthResearch & Development AI and Big Data
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| Novatex Solutions LTD | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'SME' not among eligible en…Excluded by eligibility/preference filters: Org type 'SME' not among eligible entity types ['research', 'institution']. |
Override |
| European Centre for Emerging Competencies and Technologies | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'non-profit' not among elig…Excluded by eligibility/preference filters: Org type 'non-profit' not among eligible entity types ['research', 'institution']. |
Override |